Limited data: Only 2 submissions available. Results should be interpreted with caution.

Aggregate Statistics

2 Total Submissions
10/10 Avg. Effectiveness
+50 NPS Score
8 days Time to Notice
30 days Time to Peak
100% Would Use Again
52.5 weeks Avg. Cycle Length
100% High Confidence

Effectiveness Distribution

1
2
3
4
5
6
7
8
9
10

Distribution of effectiveness ratings (1-10)

Administration Methods

Subcutaneous 2

Recommendation Score Distribution (NPS)

+50
1 Promoters (9-10) 1 Passives (7-8) 0 Detractors (0-6)
0
1
2
3
4
5
6
7
8
9
10

How likely would users recommend this peptide? (0-10)

Effect Persistence After Stopping

Still ongoing
2 (100%)

Side Effects Analysis

Most Reported Side Effects

Gastrointestinal effects (nausea, vomiting, diarrhea)—typically mild to moderate Avg severity: 3/5
1
other Avg severity: 4/5
1

Onset Timing

Early (1st week) 1

Resolution Status

Resolved (continued use) 1

Individual Submissions

Have experience with Retatrutide?

Share Your Findings